Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms HELP
Based on 32,387 articles published since 2008
|||| 50 

These are the 32387 published articles about Pancreatic Neoplasms that originated from Worldwide during 2008-2019.
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
401 Editorial Targeting neuroendocrine tumor: mixing standard options with novel therapies. 2012

Raymond, Eric / Dreyer, Chantal / Faivre, Sandrine. · ·Target Oncol · Pubmed #22918794.

ABSTRACT: -- No abstract --

402 Editorial Pancreatic cancer: steps in the right direction. 2012

Bates, Susan E. · ·Clin Cancer Res · Pubmed #22896690.

ABSTRACT: -- No abstract --

403 Editorial Proceed with caution: vascular resection at pancreaticoduodenectomy. 2012

Tseng, Jennifer F. · ·Ann Surg Oncol · Pubmed #22868922.

ABSTRACT: -- No abstract --

404 Editorial Can pharmacogenomics guide effective anticancer therapy in pancreatic ductal adenocarcinoma? 2012

Krell, Jonathan / Frampton, Adam E / Jiao, Long R / Stebbing, Justin. · ·Pharmacogenomics · Pubmed #22838942.

ABSTRACT: -- No abstract --

405 Editorial Cost effectiveness of treatment strategies for primary operable pancreatic head adenocarcinoma: do we have more scientific evidence to call for further centralization of care? 2012

Gajdos, Csaba / Schulick, Richard. · ·Ann Surg Oncol · Pubmed #22829004.

ABSTRACT: -- No abstract --

406 Editorial Prognosis of resected pancreatic cancer: is the refined resection margin status dispensable? 2012

Hartwig, Werner / Werner, Jens / Büchler, Markus W. · ·Langenbecks Arch Surg · Pubmed #22820875.

ABSTRACT: -- No abstract --

407 Editorial Flow, firmness, or FNA? Is enhanced EUS fantastic or just fancy? 2012

Romagnuolo, Joseph. · ·Gastrointest Endosc · Pubmed #22817785.

ABSTRACT: -- No abstract --

408 Editorial Research in pancreatic cancer: an update after ASCO 2012. 2012

Saif, Muhammad Wasif. · ·JOP · Pubmed #22797382.

ABSTRACT: -- No abstract --

409 Editorial Autoimmune pancreatitis (AIP) masquerading as pancreatic cancer: cutting is not a crime … for now. 2012

Zyromski, Nicholas J. · ·Dig Dis Sci · Pubmed #22732835.

ABSTRACT: -- No abstract --

410 Editorial New treatments of pancreatic neuroendocrine tumors: why using them? How to use them? 2012

Raymond, Eric / Ruszniewski, Philippe. · ·Target Oncol · Pubmed #22669625.

ABSTRACT: -- No abstract --

411 Editorial [Gastrin without a gastrinoma-editorial]. 2012

Louthan, O. · ·Vnitr Lek · Pubmed #22606745.

ABSTRACT: -- No abstract --

412 Editorial Survival from pancreatic cancer: it's not just about the surgical mortality. 2012

Padbury, Robert T A. · ·Med J Aust · Pubmed #22571298.

ABSTRACT: -- No abstract --

413 Editorial Pancreatic cancer: translational research aspects and clinical implications. 2012

Ansari, Daniel / Chen, Bi-Cheng / Dong, Lei / Zhou, Meng-Tao / Andersson, Roland. · ·World J Gastroenterol · Pubmed #22509073.

ABSTRACT: Despite improvements in surgical techniques and adjuvant chemotherapy, the overall mortality rates in pancreatic cancer have generally remained relatively unchanged and the 5-year survival rate is actually below 2%. This paper will address the importance of achieving an early diagnosis and identifying markers for prognosis and response to therapy such as genes, proteins, microRNAs or epigenetic modifications. However, there are still major hurdles when translating investigational biomarkers into routine clinical practice. Furthermore, novel ways of secondary screening in high-risk individuals, such as artificial neural networks and modern imaging, will be discussed. Drug resistance is ubiquitous in pancreatic cancer. Several mechanisms of drug resistance have already been revealed, including human equilibrative nucleoside transporter-1 status, multidrug resistance proteins, aberrant signaling pathways, microRNAs, stromal influence, epithelial-mesenchymal transition-type cells and recently the presence of cancer stem cells/cancer-initiating cells. These factors must be considered when developing more customized types of intervention ("personalized medicine"). In the future, multifunctional nanoparticles that combine a specific targeting agent, an imaging probe, a cell-penetrating agent, a biocompatible polymer and an anti-cancer drug may become valuable for the management of patients with pancreatic cancer.

414 Editorial The confusion around neuroendocrine tumors. 2012

Hendlisz, Alain / Deleporte, Amélie. · ·Curr Opin Oncol · Pubmed #22476192.

ABSTRACT: -- No abstract --

415 Editorial Pancreatic cancer: between bench and bedside. 2012

Melisi, Davide / Budillon, Alfredo. · ·Curr Drug Targets · Pubmed #22458518.

ABSTRACT: -- No abstract --

416 Editorial Pancreas cancer treatment: a surgeon's perspective today. 2012

Coppola, Roberto. · ·Int J Surg · Pubmed #22430280.

ABSTRACT: -- No abstract --

417 Editorial Strategy to differentiate autoimmune pancreatitis from pancreas cancer. 2012

Takuma, Kensuke / Kamisawa, Terumi / Gopalakrishna, Rajesh / Hara, Seiichi / Tabata, Taku / Inaba, Yoshihiko / Egawa, Naoto / Igarashi, Yoshinori. · ·World J Gastroenterol · Pubmed #22416175.

ABSTRACT: Autoimmune pancreatitis (AIP) is a newly described entity of pancreatitis in which the pathogenesis appears to involve autoimmune mechanisms. Based on histological and immunohistochemical examinations of various organs of AIP patients, AIP appears to be a pancreatic lesion reflecting a systemic "IgG4-related sclerosing disease". Clinically, AIP patients and patients with pancreatic cancer share many features, such as preponderance of elderly males, frequent initial symptom of painless jaundice, development of new-onset diabetes mellitus, and elevated levels of serum tumor markers. It is of uppermost importance not to misdiagnose AIP as pancreatic cancer. Since there is currently no diagnostic serological marker for AIP, and approach to the pancreas for histological examination is generally difficult, AIP is diagnosed using a combination of clinical, serological, morphological, and histopathological features. Findings suggesting AIP rather than pancreatic cancer include: fluctuating obstructive jaundice; elevated serum IgG4 levels; diffuse enlargement of the pancreas; delayed enhancement of the enlarged pancreas and presence of a capsule-like rim on dynamic computed tomography; low apparent diffusion coefficient values on diffusion-weighted magnetic resonance image; irregular narrowing of the main pancreatic duct on endoscopic retrograde cholangiopancreatography; less upstream dilatation of the main pancreatic duct on magnetic resonance cholangiopancreatography, presence of other organ involvement such as bilateral salivary gland swelling, retroperitoneal fibrosis and hilar or intrahepatic sclerosing cholangitis; negative work-up for malignancy including endoscopic ultrasound-guided fine needle aspiration; and steroid responsiveness. Since AIP responds dramatically to steroid therapy, accurate diagnosis of AIP can avoid unnecessary laparotomy or pancreatic resection.

418 Editorial [Pancreatic tumor: progress in diagnosis and treatment. Editorial: trend of clinical management of pancreatic tumors]. 2012

Shimosegawa, Tooru. · ·Nihon Naika Gakkai Zasshi · Pubmed #22413454.

ABSTRACT: -- No abstract --

419 Editorial Revising you the staging for pancreatic cancer in 2012. 2012

Saif, Muhammad Wasif. · ·JOP · Pubmed #22406582.

ABSTRACT: -- No abstract --

420 Editorial Pancreatic neoplasm in 2012: an update. Tissue is an issue! 2012

Saif, Muhammad Wasif. · ·JOP · Pubmed #22406581.

ABSTRACT: -- No abstract --

421 Editorial Targeting opioidergic pathways as a novel biological treatment for advanced pancreatic cancer. 2012

Zagon, Ian S / McLaughlin, Patricia J. · ·Expert Rev Gastroenterol Hepatol · Pubmed #22375517.

ABSTRACT: -- No abstract --

422 Editorial Cystic lesions of the pancreas: more reliable differentiation with in situ high-resolution optical imaging? 2012

Iftimia, Nicusor / Yoon, Won Jae / Brugge, William R. · ·Expert Rev Gastroenterol Hepatol · Pubmed #22375515.

ABSTRACT: -- No abstract --

423 Editorial Targeted therapies for pancreatic cancer. 2012

Ma, Qingyong. · ·Curr Pharm Des · Pubmed #22372496.

ABSTRACT: -- No abstract --

424 Editorial The promise and perils of measuring circulating tumor cells. 2012

Markman, Maurie. · ·Oncology · Pubmed #22270101.

ABSTRACT: -- No abstract --

425 Editorial Intraductal papillary mucinous neoplasms of the biliary and pancreatic ducts--a shape shifting outlook into an increasingly recognized disease. 2012

Crippa, Stefano / Falconi, Massimo. · ·Dig Liver Dis · Pubmed #22265327.

ABSTRACT: -- No abstract --

Back · Next